Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,087 | -51,283 | -31,591 | -16,971 | -46,658 |
| Depreciation Amortization | 349 | 332 | 282 | 298 | 445 |
| Accounts payable and accrued liabilities | -4,866 | 9,668 | 797 | 448 | -3,444 |
| Other Working Capital | -2,952 | 9,352 | -4,121 | -98 | -3,486 |
| Other Operating Activity | 4,917 | -6,473 | 636 | 1,270 | 27,339 |
| Operating Cash Flow | $-46,639 | $-38,405 | $-33,996 | $-15,053 | $-25,803 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 88 | N/A | N/A | N/A |
| PPE Investments | -11 | -26 | -36 | -4 | 3 |
| Purchase Of Investment | N/A | N/A | 21 | 5 | 3 |
| Purchase Sale Intangibles | N/A | N/A | -12 | N/A | N/A |
| Other Investing Activity | 279 | 353 | -13 | 0 | 0 |
| Investing Cash Flow | $269 | $415 | $-28 | $1 | $5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,000 | 20,000 | N/A | 3,250 |
| Debt Repayment | -12,000 | N/A | -7,784 | N/A | N/A |
| Common Stock Issued | 19,656 | N/A | 102,603 | 7,643 | 14,757 |
| Other Financing Activity | 3,064 | -275 | -4,952 | -470 | 1,085 |
| Financing Cash Flow | $10,721 | $4,725 | $109,867 | $7,173 | $19,092 |
| Beginning Cash Position | 56,902 | 90,168 | 14,324 | 22,203 | 28,909 |
| End Cash Position | 21,252 | 56,902 | 90,168 | 14,324 | 22,203 |
| Net Cash Flow | $-35,650 | $-33,266 | $75,844 | $-7,879 | $-6,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,639 | -38,405 | -33,996 | -15,053 | -25,803 |
| Capital Expenditure | -11 | -27 | -36 | -5 | -3 |
| Free Cash Flow | -46,650 | -38,432 | -34,032 | -15,058 | -25,806 |